Still, upstream regulators of NNMT in cancer were shown to be diverse, as in BRCA1 for ovarian cancer, HNF1β for thyroid cancer, and SHH for pancreatic cancer [60]. This evidence concerns the gene SHH and thyroid gland carcinoma.